EPIX

ESSA Pharma
EPIX

Delisted

EPIX was delisted on the 8th of October, 2025.

11 hedge funds and large institutions have $15.3M invested in ESSA Pharma in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.25%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
3
Increased
5
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
CV
1
Clarus Ventures
Massachusetts
$6.37M +$5.97M +1,562,500 +1,473%
OFM
2
Omega Fund Management
Massachusetts
$4.12M +$3.8M +1,000,000 +1,179%
BI
3
BVF Inc
California
$1.94M +$1.94M +509,182 New
EAM
4
Eventide Asset Management
Massachusetts
$1.83M +$1.31M +346,000 +254%
CIBC World Market
5
CIBC World Market
Ontario, Canada
$769K
CH
6
CVI Holdings
Delaware
$219K +$219K +57,338 New
Citadel Advisors
7
Citadel Advisors
Florida
$10K +$2.25K +603 +29%
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$8K -$110 -29 -1%
UBS Group
9
UBS Group
Switzerland
$6K +$4.44K +1,177 +285%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$3K -$10K -2,639 -77%